- Home
- ASRT vs DXR Comparison
ASRT vs DXR Comparison
Compare ASRT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASRT | DXR |
|---|---|---|
| Founded | 1995 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 61.1M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASRT | DXR |
|---|---|---|
| Price | $9.94 | $13.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $45.00 | $25.00 |
| AVG Volume (30 Days) | ★ 30.2K | 2.6K |
| Earning Date | 11-10-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.46 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $137,354,000.00 | $66,306.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $38.57 |
| Revenue Growth | ★ 9.22 | N/A |
| 52 Week Low | $7.71 | $6.55 |
| 52 Week High | $15.15 | $14.15 |
Technical Indicators
Market Signals| Indicator | ASRT | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 98.16 | 63.46 |
| Support Level | $0.61 | $12.00 |
| Resistance Level | $0.75 | $12.90 |
| Average True Range (ATR) | 0.10 | 0.41 |
| MACD | 0.58 | 0.14 |
| Stochastic Oscillator | 94.90 | 100.00 |
Price Performance
Historical ComparisonAbout ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.